Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction.
about
Enteroendocrine cells: neglected players in gastrointestinal disorders?An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered MicrobiomeNeuroimmunomodulation in the Gut: Focus on Inflammatory Bowel DiseaseRegulation of the serotonin transporter in the pathogenesis of irritable bowel syndromeMechanosensory Signaling in Enterochromaffin Cells and 5-HT Release: Potential Implications for Gut InflammationInterplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowelCD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work?Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic RelevanceSerotonin and GI Disorders: An Update on Clinical and Experimental Studies.Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infectionEpithelial stem cell-related alterations in Trichinella spiralis-infected small intestine.Review article: intestinal serotonin signalling in irritable bowel syndrome.Cryptosporidium parvum isolate-dependent postinfectious jejunal hypersensitivity and mast cell accumulation in an immunocompetent rat model.Gut hormones: emerging role in immune activation and inflammation.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice.Principles and clinical implications of the brain-gut-enteric microbiota axis.Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case reportOntogeny and regulation of the serotonin transporter: providing insights into human disorders.Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid.Changing views on diverticular disease: impact of aging, obesity, diet, and microbiota.Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in RatsIBS and IBD - separate entities or on a spectrum?Serotonin is a sword and a shield of the bowel: serotonin plays offense and defenseHistopathological alterations in irritable bowel syndrome.Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women?Mechanisms of hypersensitivity in IBS and functional disorders.Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression.Physiological changes in the gastrointestinal tract and host protective immunity: learning from the mouse-Trichinella spiralis model.Th17: a new participant in gut dysfunction in mice infected with Trichinella spiralisRole of chemical stimulation of the duodenum in dyspeptic symptom generation.Is irritable bowel syndrome an organic disorder?Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment.5-HT7 receptor signaling: improved therapeutic strategy in gut disorders
P2860
Q24629026-E76D7F71-E624-484D-B795-DAF799938E27Q24630575-AFB66183-307B-4E69-83E0-985705AD3328Q26741037-E468C199-7AED-40B0-94BD-8201482FE5DAQ28072085-7A4A6F41-1598-4EAF-A8E6-8A9315274334Q28817153-270B5CD5-4C88-4A86-9DF3-0EA34FF984CFQ28822420-1AA1AC10-62F8-4C2C-879F-5A5933DDCC60Q33274027-9A827A26-1492-4734-98BE-F0CC6C8CA3EAQ33531535-D9F6BAF2-130B-4517-B78F-3670CCFD3AF3Q33661084-859232E0-44F3-4CB0-8021-664C80ECADF4Q33724343-B5195F63-1247-4315-90F2-998D8D6BCA9EQ33926234-AB2B5A52-4F17-4B6C-BE01-7ACCCBC7FD1CQ34317503-4646879B-1F4E-49FC-A078-8E3AC659015CQ34415870-433DC699-0FC7-4201-B5B3-707A0DD0562DQ34475786-919E636C-A3A7-4900-8AFA-B6420680728CQ34566461-1244256D-99A3-4B98-A5CC-874ABC68151FQ34610874-17C07CD0-415C-48C6-A106-6409CA487B89Q34618925-B8372D8C-D026-4C20-AE9E-614B98040D1AQ34626602-57A0349A-1B71-4908-BEE3-C27801A1040AQ34742010-401BEC15-4585-400B-9CC2-383A5CE2D58AQ34978494-0457F404-F3DB-42A7-8CBD-B7303831AA57Q35001118-C7AE579E-2E52-4028-89F2-D0D74CBAC59DQ35090255-12937F07-1A1F-459C-912F-8ECD806B949BQ35178813-7189BBF7-9592-4ED0-B56C-AF0B8C6970CDQ35565092-F866AD55-3EFA-4F09-8E90-FF721B2900ECQ35590592-8CA64F05-3CC7-401B-A9ED-0F8AABA986ADQ36036768-B692C505-DB00-4E6F-B2E4-3B09F7ECB841Q36144375-8D3BA0BB-2AA2-4805-9E69-9F1CC48CEF48Q36519716-055F0E2A-A81A-425C-AA3E-506A35EA387DQ36609410-906AFE9B-4EA9-41E8-A979-5C530551BEBAQ36687444-B8752646-73A9-4FCE-B291-D503908D0F65Q36728934-0EBB3E26-3C52-4810-9C2C-17D986EE7F3FQ36874385-65D0E3E5-F608-46C2-A7E6-F0AABC85458FQ36998938-0BF16EE5-02D1-46DD-BB94-309D0CFDAB44Q37055770-749DA220-DF84-4B9D-A311-6D9BA38A558CQ37172041-A99130C0-3DF5-42FB-BC35-DCA97D94A678Q37452755-B672DEA7-3020-4493-BA27-6A6B81B93D43Q37710362-7309DA7D-B33E-4CE6-800E-F88018E47F5EQ38191561-7C117536-831F-4C92-BC18-CE1F4FD60A00Q38192048-052C07DE-8B35-412E-9D80-1BA40AB4FB45Q38310117-1E52C079-A7FC-49BB-804B-A8DC538FBAAC
P2860
Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@en
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@nl
type
label
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@en
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@nl
prefLabel
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@en
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@nl
P2093
P2860
P1476
Enterochromaffin cell hyperpla ...... tinfectious bowel dysfunction.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2982.2005.00719.X
P577
2005-12-01T00:00:00Z